Volume 15, Number 12—December 2009
Community-associated Methicillin-Resistant Staphylococcus aureus in Outpatients, United States, 1999–2006
MedscapeCME is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of MedscapeCME and Emerging Infectious Diseases. MedscapeCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. MedscapeCME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at http://www.medscape.com/cme/eid; (4) view/print certificate.
Upon completion of this activity, participants will be able to:
Specify characteristics of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) compared with hospital-acquired MRSA
Recognize recent trends in MRSA among outpatients
Identify anatomic sites most commonly associated with infection with MRSA resistant only to oxacillin
Recognize recent trends in MRSA among inpatients
Describe the most common treatment for rickettsial diseases.
Thomas Gryczan, Technical Writer-Editor, Emerging Infectious Diseases. Disclosure: Thomas Gryczan has disclosed no relevant financial relationships.
Charles P. Vega, MD, Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Eili Klein, MA; David L. Smith, PhD; and Ramanan Laxminarayan, PhD, MPH, have disclosed no relevant financial relationships.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: December 09, 2010
- Page last updated: December 09, 2010
- Page last reviewed: December 09, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)